BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rice TW, Lerut TE, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, van Lanschot J, Chen KN, Davies AR. Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data. Dis Esophagus. 2016;29:715-723. [PMID: 27731548 DOI: 10.1111/dote.12513] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Kang J, Lee HP, Kim HR, Kim JH, Jung HY, Lee GH, Song HJ, Kim DH, Choi KD, Ahn JY, Ryu JS, Cho KJ, Lee MY, Kim SB, Kim YH, Park SR. Validation of the post-neoadjuvant staging system of the American joint committee on cancer, 8th edition, in patients treated with neoadjuvant chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma. Surg Oncol 2020;35:491-7. [PMID: 33130441 DOI: 10.1016/j.suronc.2020.10.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Park SY, Kim DJ, Suh JW, Byun GE. Comparison of the 11th Japanese classification and the AJCC 7th and 8th staging systems in esophageal squamous cell carcinoma patients. J Thorac Dis 2018;10:5039-46. [PMID: 30233878 DOI: 10.21037/jtd.2018.07.48] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Griffin N, Rowe CW, Gao F, Jobling P, Wills V, Walker MM, Faulkner S, Hondermarck H. Clinicopathological Significance of Nerves in Esophageal Cancer. Am J Pathol 2020;190:1921-30. [PMID: 32479822 DOI: 10.1016/j.ajpath.2020.05.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Rice TW, Gress DM, Patil DT, Hofstetter WL, Kelsen DP, Blackstone EH. Cancer of the esophagus and esophagogastric junction-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:304-317. [PMID: 28556024 DOI: 10.3322/caac.21399] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 18.4] [Reference Citation Analysis]
5 Sisic L, Blank S, Nienhüser H, Dorr S, Haag GM, Jäger D, Bruckner T, Müller-Stich BP, Ott K, Büchler MW, Ulrich A, Schmidt T. Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment. Eur J Surg Oncol 2018;44:1646-56. [PMID: 30082176 DOI: 10.1016/j.ejso.2018.06.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
6 Rice TW, Ishwaran H, Hofstetter WL, Kelsen DP, Apperson-Hansen C, Blackstone EH; Worldwide Esophageal Cancer Collaboration Investigators. Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 2016;29:897-905. [PMID: 27905172 DOI: 10.1111/dote.12533] [Cited by in Crossref: 57] [Cited by in F6Publishing: 68] [Article Influence: 11.4] [Reference Citation Analysis]
7 Jayaprakasam VS, Yeh R, Ku GY, Petkovska I, Fuqua JL 3rd, Gollub M, Paroder V. Role of Imaging in Esophageal Cancer Management in 2020: Update for Radiologists. AJR Am J Roentgenol 2020;215:1072-84. [PMID: 32901568 DOI: 10.2214/AJR.20.22791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Jiang D, Wang H, Song Q, Wang H, Wang Q, Tan L, Hou Y. Comparison of the prognostic difference between ypTNM and equivalent pTNM stages in esophageal squamous cell carcinoma based on the 8th edition of AJCC classification. J Cancer 2020;11:1808-15. [PMID: 32194792 DOI: 10.7150/jca.34567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Rice TW, Blackstone EH. Staging of Cancer of the Esophagus and Esophagogastric Junction. In: Saba NF, El-rayes BF, editors. Esophageal Cancer. Cham: Springer International Publishing; 2020. pp. 127-37. [DOI: 10.1007/978-3-030-29832-6_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Puetz K, Bollschweiler E, Semrau R, Mönig SP, Hölscher AH, Drebber U. Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination? Histopathology 2019;74:731-43. [PMID: 30636069 DOI: 10.1111/his.13811] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
11 Rice TW, Patil DT, Blackstone EH. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg. 2017;6(2):119-130. [PMID: 28447000 DOI: 10.21037/acs.2017.03.14] [Cited by in Crossref: 186] [Cited by in F6Publishing: 152] [Article Influence: 37.2] [Reference Citation Analysis]
12 Yap W, Chang Y, Hsieh C, Chao Y, Chen C, Shih M, Hung T. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy. Eur J Nucl Med Mol Imaging 2018;45:689-98. [DOI: 10.1007/s00259-017-3901-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
13 D'Journo XB. Clinical implication of the innovations of the 8th edition of the TNM classification for esophageal and esophago-gastric cancer. J Thorac Dis 2018;10:S2671-81. [PMID: 30345104 DOI: 10.21037/jtd.2018.03.182] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
14 Hu K, Kang N, Liu Y, Guo D, Jing W, Lu J, Tan T, Lv C, Deng Y, Long J, Wang R, Yu J. Proposed revision of N categories to the 8th edition of the AJCC-TNM staging system for non-surgical esophageal squamous cell cancer. Cancer Sci 2019;110:717-25. [PMID: 30467921 DOI: 10.1111/cas.13891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Escrig Sos J, Gómez Quiles L, Maiocchi K. The 8th edition of the AJCC-TNM classification: New contributions to the staging of esophagogastric junction cancer. Cir Esp (Engl Ed) 2019;97:432-7. [PMID: 31029372 DOI: 10.1016/j.ciresp.2019.03.006] [Reference Citation Analysis]
16 Sudo N, Ichikawa H, Muneoka Y, Hanyu T, Kano Y, Ishikawa T, Hirose Y, Miura K, Shimada Y, Nagahashi M, Sakata J, Kobayashi T, Bamba T, Nakagawa S, Kosugi SI, Wakai T. ASO Author Reflections: ypTNM Stage Grouping in the 8th Edition of the AJCC Cancer Staging Manual Refines the Prognostic Prediction for Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol 2021;28:661-2. [PMID: 33001302 DOI: 10.1245/s10434-020-09184-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Raja S, Rice TW, Murthy SC, Ahmad U, Semple ME, Blackstone EH, Ishwaran H; Worldwide Esophageal Cancer Collaboration Investigators. Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma. Ann Surg 2021;274:e320-7. [PMID: 31850981 DOI: 10.1097/SLA.0000000000003598] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
18 Rice TW, Ishwaran H, Kelsen DP, Hofstetter WL, Apperson-Hansen C, Blackstone EH; Worldwide Esophageal Cancer Collaboration Investigators. Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 2016;29:906-912. [PMID: 27905170 DOI: 10.1111/dote.12538] [Cited by in Crossref: 34] [Cited by in F6Publishing: 42] [Article Influence: 6.8] [Reference Citation Analysis]
19 Ye G, Chen Z, Wang L, Hu Z, Bian Y, Yang X, Lu T, Zhan C, Lin Z, Wang Q. Log odds of positive lymph nodes predicts survival in patients treated with neoadjuvant therapy followed by esophagectomy. J Surg Oncol 2020;121:1074-83. [PMID: 32141098 DOI: 10.1002/jso.25888] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Thomaschewski M, Hummel R, Petrova E, Knief J, Wellner UF, Keck T, Bausch D. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours. World J Gastroenterol 2018; 24(13): 1429-1439 [PMID: 29632424 DOI: 10.3748/wjg.v24.i13.1429] [Reference Citation Analysis]
21 Chang X, Deng W, Ni W, Li C, Han W, Gao LR, Wang S, Zhou Z, Chen D, Feng Q, Bi N, Gao S, Lin Y, Chen J, Xiao Z. Comparison of Two Major Staging Systems in Predicting Survival and Recommendation of Postoperative Radiotherapy Based on the 11th Japanese Classification for Esophageal Carcinoma After Curative Resection: A Propensity Score-Matched Analysis. Ann Surg Oncol 2021. [PMID: 33969465 DOI: 10.1245/s10434-021-10046-6] [Reference Citation Analysis]
22 Depypere LP, Moons J, Lerut TE, Coosemans W, Van Veer H, Nafteux PR. Palliative esophagectomy in unexpected metastatic disease: sense or nonsense? Asian Cardiovasc Thorac Ann 2018;26:552-7. [PMID: 30185072 DOI: 10.1177/0218492318797228] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
23 Yuan Y, Hong HG, Zeng X, Xu L, Yang Y, Shang Q, Yang H, Li Y, Li Y, Wu Z, Fu J, Yao X, Xu X, Wu J, Chen L. Lymph Node Station-Based Nodal Staging System for Esophageal Squamous Cell Carcinoma: A Large-Scale Multicenter Study. Ann Surg Oncol 2019;26:4045-52. [DOI: 10.1245/s10434-019-07601-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
24 Hsu PK, Chen HS, Liu CC, Wu SC. Application of the Eighth AJCC TNM Staging System in Patients With Esophageal Squamous Cell Carcinoma. Ann Thorac Surg 2018;105:1516-22. [PMID: 29409986 DOI: 10.1016/j.athoracsur.2017.12.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
25 Rice TW, Lu M, Ishwaran H, Blackstone EH; Worldwide Esophageal Cancer Collaboration Investigators. Precision Surgical Therapy for Adenocarcinoma of the Esophagus and Esophagogastric Junction. J Thorac Oncol. 2019;14:2164-2175. [PMID: 31442498 DOI: 10.1016/j.jtho.2019.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Li Y, Du L, Wang Y, Gu Y, Zhen X, Hu X, Sun X, Dong H. Modeling the Cost-effectiveness of Esophageal Cancer Screening in China. Cost Eff Resour Alloc 2020;18:33. [PMID: 32944005 DOI: 10.1186/s12962-020-00230-y] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Soo RA, Stone EC, Cummings KM, Jett JR, Field JK, Groen HJ, Mulshine JL, Yatabe Y, Bubendorf L, Dacic S, Rami-porta R, Detterbeck FC, Lim E, Asamura H, Donington J, Wakelee HA, Wu Y, Higgins K, Senan S, Solomon B, Kim D, Johnson M, Yang JC, Sequist LV, Shaw AT, Ahn M, Costa DB, Patel JD, Horn L, Gettinger S, Peters S, Wynes MW, Faivre-finn C, Rudin CM, Tsao A, Baas P, Kelly RJ, Leighl NB, Scagliotti GV, Gandara DR, Hirsch FR, Spigel DR. Scientific Advances in Thoracic Oncology 2016. Journal of Thoracic Oncology 2017;12:1183-209. [DOI: 10.1016/j.jtho.2017.05.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
28 Sudo N, Ichikawa H, Muneoka Y, Hanyu T, Kano Y, Ishikawa T, Hirose Y, Miura K, Shimada Y, Nagahashi M, Sakata J, Kobayashi T, Bamba T, Nakagawa S, Kosugi SI, Wakai T. Clinical Utility of ypTNM Stage Grouping in the 8th Edition of the American Joint Committee on Cancer TNM Staging System for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021;28:650-60. [PMID: 33025354 DOI: 10.1245/s10434-020-09181-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
29 Solomon D, Abbas M, Feferman Y, Haddad R, Perl G, Kundel Y, Morgenstern S, Menasherov N, Kashtan H. Signet Ring Cell Features are Associated with Poor Response to Neoadjuvant Treatment and Dismal Survival in Patients with High-Grade Esophageal Adenocarcinoma. Ann Surg Oncol 2021;28:4929-40. [PMID: 33709175 DOI: 10.1245/s10434-021-09644-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P. Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer. J Thorac Oncol. 2017;12:36-42. [PMID: 27810391 DOI: 10.1016/j.jtho.2016.10.016] [Cited by in Crossref: 160] [Cited by in F6Publishing: 188] [Article Influence: 26.7] [Reference Citation Analysis]
31 Dreyfuss AD, Barsky AR, Wileyto EP, Eads JR, Kucharczuk JC, Williams NN, Karasic TB, Metz JM, Ben-Josef E, Plastaras JP, Wojcieszynski AP. The efficacy and safety of definitive concurrent chemoradiotherapy for non-operable esophageal cancer. Cancer Med 2021;10:1275-88. [PMID: 33474812 DOI: 10.1002/cam4.3724] [Reference Citation Analysis]
32 Wu Z, Zheng Q, Chen H, Xiang J, Hu H, Li H, Pan Y, Peng Y, Yao X, Liu P, Sun Y, Li B, Zhang Y. Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma. J Thorac Dis 2021;13:3518-28. [PMID: 34277047 DOI: 10.21037/jtd-21-340] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Zhang D, Zheng Y, Wang Z, Huang Q, Cao X, Wang F, Liu S. Comparison of the 7th and proposed 8th editions of the AJCC/UICC TNM staging system for esophageal squamous cell carcinoma underwent radical surgery. Eur J Surg Oncol. 2017;43:1949-1955. [PMID: 28716377 DOI: 10.1016/j.ejso.2017.06.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
34 Oshikiri T, Goto H, Kato T, Sawada R, Harada H, Urakawa N, Hasegawa H, Kanaji S, Yamashita K, Matsuda T, Fujino Y, Tominaga M, Kakeji Y. Proposed modification of the eighth edition of the AJCC-ypTNM staging system of esophageal squamous cell cancer treated with neoadjuvant chemotherapy: Unification of the AJCC staging system and the Japanese classification. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.01.014] [Reference Citation Analysis]
35 Yuan Y, Ma G, Hu X, Huang Q. Evaluating the eighth edition TNM staging system for esophageal cancer among patients receiving neoadjuvant therapy: A SEER study. Cancer Med 2020;9:4648-55. [PMID: 32391623 DOI: 10.1002/cam4.2997] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Depypere LP, Moons J, Mariette C, D’journo XB, Thomas PA, Hölscher AH, Bollschweiler E, van Berge-henegouwen MI, Van Lanschot JJB, Lerut TEMR, Nafteux PR. Impact of Extracapsular Lymph Node Involvement After Neoadjuvant Chemoradiation Therapy Followed by Surgery in Carcinoma of the Esophagus: A Multicenter Study. Annals of Surgery 2018;268:1000-7. [DOI: 10.1097/sla.0000000000002425] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]